About Nautilus Biotechnology
Nautilus Biotechnology is a company based in Seattle (United States) founded in 2016 by Sujal Patel and Parag Mallick.. Nautilus Biotechnology has raised $103.26 million across 5 funding rounds from investors including Amazon, Perceptive Advisors and Vulcan Aerospace. The company has 155 employees as of December 31, 2024. Nautilus Biotechnology offers products and services including Proteome Analysis Platform and Targeted Proteoform Analysis. Nautilus Biotechnology operates in a competitive market with competitors including Somalogic, Amunix, Biognosys, Elektrofi and ProteinSimple, among others.
- Headquarter Seattle, United States
- Employees 155 as on 31 Dec, 2024
- Founders Sujal Patel, Parag Mallick
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nautilus Biotechnology, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-70.78 M-11.16as on Dec 31, 2024
-
EBITDA
$-75.12 M-6.64as on Dec 31, 2024
-
Total Equity Funding
$103.26 M (USD)
in 5 rounds
-
Latest Funding Round
$14.7 M (USD), Post-IPO
Aug 05, 2021
-
Investors
Amazon
& 7 more
-
Employee Count
155
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nautilus Biotechnology
Nautilus Biotechnology is a publicly listed company on the NASDAQ with ticker symbol NAUT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nautilus Biotechnology
Nautilus Biotechnology offers a comprehensive portfolio of products and services, including Proteome Analysis Platform and Targeted Proteoform Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform quantifies proteins for discovery in biological research applications.
Analyzes protein variants to drive insights in drug and biomarker fields.
Unlock access to complete
Unlock access to complete
Funding Insights of Nautilus Biotechnology
Nautilus Biotechnology has successfully raised a total of $103.26M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $14.7 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $14.7M
-
First Round
First Round
(30 May 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Post-IPO - Nautilus Biotechnology | Valuation |
investors |
|
| Jun, 2021 | Amount | Post-IPO - Nautilus Biotechnology | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Nautilus Biotechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nautilus Biotechnology
Nautilus Biotechnology has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Amazon, Perceptive Advisors and Vulcan Aerospace. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management and philanthropic ventures linked to Bezos Expeditions.
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are made in US geographies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nautilus Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nautilus Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nautilus Biotechnology Comparisons
Competitors of Nautilus Biotechnology
Nautilus Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Amunix, Biognosys, Elektrofi and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Digital platform transforming the delivery of biologic medicines
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nautilus Biotechnology
Frequently Asked Questions about Nautilus Biotechnology
When was Nautilus Biotechnology founded?
Nautilus Biotechnology was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Nautilus Biotechnology located?
Nautilus Biotechnology is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of Nautilus Biotechnology?
Sujal Patel is the current CEO of Nautilus Biotechnology. They have also founded this company.
Is Nautilus Biotechnology a funded company?
Nautilus Biotechnology is a funded company, having raised a total of $103.26M across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $350M, raised on May 30, 2018.
How many employees does Nautilus Biotechnology have?
As of Dec 31, 2024, the latest employee count at Nautilus Biotechnology is 155.
What does Nautilus Biotechnology do?
Nautilus Biotechnology was founded in 2016 and is headquartered in Seattle, United States. A proteomics platform is being developed to analyze and quantify proteins in the human proteome, utilizing patent-protected technology. This platform supports applications in drug development and precision medicine within the biotechnology sector. Operations focus on enhancing protein quantification sensitivity for research purposes.
Who are the top competitors of Nautilus Biotechnology?
What products or services does Nautilus Biotechnology offer?
Nautilus Biotechnology offers Proteome Analysis Platform and Targeted Proteoform Analysis.
Is Nautilus Biotechnology publicly traded?
Yes, Nautilus Biotechnology is publicly traded on NASDAQ under the ticker symbol NAUT.
Who are Nautilus Biotechnology's investors?
Nautilus Biotechnology has 8 investors. Key investors include Amazon, Perceptive Advisors, Vulcan Aerospace, Bezos Expeditions, and defy vc.
What is Nautilus Biotechnology's ticker symbol?
The ticker symbol of Nautilus Biotechnology is NAUT on NASDAQ.